Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Oncogene|August 26, 1998
FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomasW J Maerz, J Baselga, V E Reuter, et al.
Cell Cycle (Georgetown, Tex.)|September 15, 2017
G0S2 represses PI3K/mTOR signaling and increases sensitivity to PI3K/mTOR pathway inhibitors in breast cancerChristina Y Yim, Emmanuel Bikorimana, Ema Khan, et al.
Endocrinology|January 21, 2025
A Dynamic Shift in Estrogen Receptor Expression During Granulosa Cell Differentiation in the OvaryChan Jin Park, Ji-Eun Oh, PoChing Lin, et al.
Cancers|June 12, 2019
Epigenetic Remodeling through Downregulation of Polycomb Repressive Complex 2 Mediates Chemotherapy Resistance in Testicular Germ Cell TumorsRatnakar Singh, Zeeshan Fazal, Andrea K Corbet, et al.
BMC Cancer|October 31, 2009
Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targetingGrace E Snow, Allison C Kasper, Alexander M Busch, et al.
Plos One|January 10, 2013
Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylationBijesh K Biswal, Maroun J Beyrouthy, Mary P Hever-Jardine, et al.
Cancer Research|February 4, 2016
G0S2 Suppresses Oncogenic Transformation by Repressing a MYC-Regulated Transcriptional ProgramChristina Y Yim, David J Sekula, Mary P Hever-Jardine, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 23, 2023
β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancerEric R Reed, Stacy A Jankowski, Anthony J Spinella, et al.
Nutrients|November 27, 2021
Per- and Polyfluoroalkyl Substance Exposure Combined with High-Fat Diet Supports Prostate Cancer ProgressionOzan Berk Imir, Alanna Zoe Kaminsky, Qian-Ying Zuo, et al.
Plos One|December 7, 2013
Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastomaPingping Mao, Mary P Hever-Jardine, Gilbert J Rahme, et al.
Pageof 9